Diclofenac

Arthropathy

Express Specialty PharmacySmall moleculePhase 4 / ApprovedDormant

BBB

73/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 58/ 100
Competitive Position: 95/ 100

Competitive context

2 Active assets in the Arthropathy cohort.

Asset / Sponsor	Phase	Rating
Desflurane Pedro Paulo Tanaka	Phase 4	BB
Propofol Pedro Paulo Tanaka	Phase 4	BB
Testosterone Undecylate Alliance for Clinical Trials in Oncology	Phase 3	BB
Letrozole ARKAY Therapeutics	Phase 2	BB
Gabapentin British Columbia Cancer Agency	Phase 2/3	B

View all 32 →

Same molecule, other indications

Diclofenac is also rated in:

chronic pain syndromeActive

BB

Indicative · Phase 4

66 / 100

subarachnoid hemorrhageDormant

BB

Indicative · Phase 4

65 / 100

migraine without auraActive

BB

Indicative · Phase 4

65 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.